Phase 2 Optic Atrophy Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)

Autosomal Dominant Optic AtrophyOPA1 Gene MutationHereditary Optic Atrophies+1 more

PYC Therapeutics18 enrolled3 locationsNCT06970106

Not Yet Recruiting

Phase 2

Idebenone versus placebo in dominant optic atrophy

Dominant Optic Atrophy

Northern Sydney Local Health District40 enrolled1 locationACTRN12621000826842